ClinConnect ClinConnect Logo
Search / Trial NCT05903105

Diversity in Patients With OAB

Launched by UNIVERSITY HOSPITAL, GHENT · Jun 5, 2023

Trial Information

Current as of July 09, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial, titled "Diversity in Patients With OAB," is exploring how different people with Overactive Bladder (OAB) - a condition that causes frequent urges to urinate - prefer various treatment options. OAB affects many adults, and while initial treatments usually involve lifestyle changes and medications, some patients may need additional options like Botox injections or a device that helps control bladder function. This study aims to understand how personal factors such as culture or language might influence patients' choices between these treatments.

To participate, you should be an adult diagnosed with OAB and have not previously received Botox or sacral neuromodulation treatment. If you join, you'll complete a questionnaire that collects basic information about you and asks about your treatment preferences. The researchers want to ensure that all voices are heard, so the questionnaire will be available in multiple languages. This study is important because it could help healthcare providers offer more personalized treatment options that align with each patient's unique needs and preferences.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • OAB
  • Adult
  • Exclusion Criteria:
  • SNM or Botox in history

About University Hospital, Ghent

University Hospital Ghent is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. Located in Ghent, Belgium, the hospital is affiliated with Ghent University, fostering a collaborative environment that integrates cutting-edge medical research with high-quality patient care. With a diverse range of specialized departments and a dedicated team of researchers and clinicians, University Hospital Ghent is at the forefront of developing new therapies and improving treatment protocols, aiming to enhance patient outcomes and contribute to the global medical community.

Locations

Ghent, East Fanders, Belgium

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported